BioFocus Screening Targets for Almirall | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – BioFocus will use its screening technologies and compound collections to find new hit compounds against key targets of interest for Barcelona, Spain-based pharmaceutical firm Almirall under a new agreement announced today.

Almirall said that BioFocus will help it find new hit compounds against key targets as possible treatments for respiratory and inflammatory conditions.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.